CV and Cancer Risk with JAK inhibitors Save Jun 01, 2023 2:05 pm Dr. Jonathan Kay discusses abstract OP0132 presented at EULAR 2023 in Milan, Italy. ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment.Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.